<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852000/" ref="ordinalpos=3101&amp;ncbi_uid=5567064&amp;link_uid=PMC3852000" image-link="/pmc/articles/PMC3852000/figure/F4/" class="imagepopup">Figure 4.  From: Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in anaplastic large cell lymphoma. </a></div><br /><div class="p4l_captionBody"><b>Overexpression of NPM-ALK activated the AKT/mTOR pathway.</b> Overexpression of NPM-ALK in BaF3 cells induced hyper-activation of the AKT/mTOR pathway, as demonstrated by hyperphosphorylation of AKT and downstream molecules of mTOR: 4E-BP1 and p70SK6.</div></div>